Loading
Loading…
Loading…
Tender ID
| # | Company | Amount |
|---|---|---|
| 1 | ₹17.2 L Per unit ₹5,565 · 309 Nos. |
Tender Value
Refer Docs
EMD Value
₹60,900
Closing Date
18 May 2026, 11:00 amClosed
4 locations across Gujarat, Madhya Pradesh, Maharashtra
Ranibizumab 2.3mg Inj (Approved by CDSCO for all six indications as 1)Wet AMD, 2)Diabetic Macular Edema, 3)Retinal Vein Occlusion, 4)Myopic CNVM, 5)Proliferative Diabetic Retinopathy, 6)Retinopathy of Prematurity)
28262558
28262558
Limited - Indigenous
Goods
Unknown (Unspecified Location)
₹0
₹60,900
23 Apr 2026
23 Apr 2026
Description :Ranibizumab 2.3mg Inj (Approved by CDSCO for all six indications as 1)Wet AMD, 2)Dia betic Macular Edema, 3)Retinal Vein Occlusion, 4)Myopic CNVM, 5)Proliferative Diabetic Retinopathy, 6)Retinopathy of Prematurity) ] Divisional Rly Hosp ADI WR, WR Gujarat 20.00 Numbers Divisional Rly Hosp PRTN WR, Gujarat 50.00 Numbers WR Consignee Divisional Rly Hosp RJT WR, WR Gujarat 15.00 Numbers Divisional Rly Hosp RTM WR, WR Madhya Pradesh 24.00 Numbers Jagjivan Ram Hospital, WR Maharashtra 200.00 Numbers
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
HTML
nit.pdf
NIT
5037803.pdf
ATTACHMENT
5047457.pdf
ATTACHMENT
4803751.pdf
ATTACHMENT
5615594.pdf
ATTACHMENT
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .